Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 14
Submit an article Journal homepage
527
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine

Sangeetha Venugopala Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Abhishek Maitia Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Courtney D. DiNardoa Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Wei Qiaob Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Jing Ningb Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Sanam Loghavic Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Naval G. Davera Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Tapan M. Kadiaa Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Caitlin R. Rauschd Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Yesid Alvaradoa Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Maro Ohaniana Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Koji Sasakia Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Nicholas J. Shorta Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Koichi Takahashia Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Musa Yilmaza Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Farhad Ravandia Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Hagop M. Kantarjiana Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
&
Marina Y. Konoplevaa Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
View further author information
 show all
Pages 3501-3505 | Received 09 Jul 2021, Accepted 16 Aug 2021, Published online: 03 Sep 2021

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jan Philipp Bewersdorf, Richard M. Stone, Martin S. Tallman & Maximilian Stahl. (2021) Does the conventional cytogenetic risk profile still matter for prediction of venetoclax based treatment outcomes in AML?. Leukemia & Lymphoma 62:14, pages 3318-3319.
Read now

Articles from other publishers (1)

Nina Rosa Neuendorff, Nico Gagelmann, Surbhi Singhal, Shelby Meckstroth, Vincent Thibaud, Yue Zhao, Nabiel Mir, Yung-Yu Shih, Danielle M.C. Amaro, Mukul Roy, Joseph Lombardo, Lars Klingen Gjærde & Kah Poh Loh. (2023) Hypomethylating agent-based therapies in older adults with acute myeloid leukemia – A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee. Journal of Geriatric Oncology 14:3, pages 101406.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.